Sila Realty Trust (SILA) Q2 2025 earnings summary

Executive summary

• Delivered another positive quarter with strong operating fundamentals, prudent capital allocation, and a resilient portfolio, maintaining robust liquidity of $568.8 million.

• Focused on high-quality, necessity-based healthcare assets with 136 properties and 99.2% occupancy as of June 30, 2025, benefiting from demographic tailwinds and resilient tenancy.

• Portfolio performance driven by new leasing activity, acquisitions, and high tenant retention, with key acquisitions in Delaware and Texas.

• Strategic decision to demolish the Stoughton asset to halt expense leakage and increase portfolio lease percentage to 99.2%.

• No material pending legal proceedings or changes in risk factors during the quarter.

Financial highlights

• Q2 2025 cash NOI was $41.9 million, up 1.7% sequentially and 5% year-over-year, driven by acquisitions and same store growth.

• Total revenues for Q2 2025 were $48.7 million, up 11.9% year-over-year; net income attributable to common stockholders was $8.6 million ($0.16 per share), up from $4.6 million ($0.08 per share) in Q2 2024.

• AFFO per diluted share was $0.54, a 1.7% increase from Q1 2025, but down 2.7% year-over-year due to higher interest expense; AFFO payout ratio for the quarter was 74%.

• Distributions of $0.40 per share for Q2 2025; annualized $1.60 per share.

• Impairment losses of $3.3 million in Q2 2025, mainly due to tenant vacancy and lease terminations.

Outlook and guidance

• Over $70 million of new net lease healthcare transactions under exclusive LOI, expected to close around Q3, with cap rates in the upper end of the 6%-7.5% range.

• Management expects sufficient liquidity for the next twelve months, with $24.8 million in cash and $544 million available under the credit facility.

• Confident in ability to renew nearly all 2025 and 2026 lease expirations, with minimal expected vacancy impact.

• Committed to external growth through accretive acquisitions and maintaining a strong dividend.

• Board authorized a new $75 million, three-year share repurchase program in August 2025.